Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COBALT: Coversin Global Study in PNH Patients
2016-002067-33Phase 2Completed
- Sponsor
- Akari Therapeutics
- Start
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nomacopan in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Akari Therapeutics. Started Aug 2016; status: completed.
02
Drugs
nomacopan
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on 2016-002067-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002067-33.